Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation

Belinostat approved for use in treating rare lymphoma

(2014) C. A. Thompson   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Nivolumab: Promising Survival Signal Coupled With Limited Toxicity Raises Expectations

(2014) Geraldine O'Sullivan Coyne et al.   JOURNAL OF CLINICAL ONCOLOGY

A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs

(2014) Fengdong Cheng et al.   JOURNAL OF IMMUNOLOGY

The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity

(2013) David M. Woods et al.   MELANOMA RESEARCH

Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth

(2012) Joel A. Bergman et al.   JOURNAL OF MEDICINAL CHEMISTRY

HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma

(2011) D. Buglio et al.   BLOOD

Histone Deacetylase Inhibition by Sodium Valproate Regulates Polarization of Macrophage Subsets

(2011) Chenming Wu et al.   DNA AND CELL BIOLOGY

Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer

(2011) Karrune V Woan et al.   IMMUNOLOGY AND CELL BIOLOGY

Melanoma surveillance in the United States: Overview of methods

(2011) Meg Watson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3+ T-Regulatory Cells

(2011) E. F. de Zoeten et al.   MOLECULAR AND CELLULAR BIOLOGY

Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy

(2011) S Spiegel et al.   ONCOGENE

Epidemiology of Melanoma

(2011) Darrell S. Rigel   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824

(2009) D. D. Vo et al.   CANCER RESEARCH

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

(2009) Richard L. Piekarz et al.   JOURNAL OF CLINICAL ONCOLOGY

Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions

(2009) C. Choudhary et al.   SCIENCE

Use of the Nitrile Oxide Cycloaddition (NOC) Reaction for Molecular Probe Generation: A New Class of Enzyme Selective Histone Deacetylase Inhibitors (HDACIs) Showing Picomolar Activity at HDAC6

(2008) Alan P. Kozikowski et al.   JOURNAL OF MEDICINAL CHEMISTRY